EML supply-demand gap sits above 30% and they just added $250 million to the guide with no capacity relief in sight.
Thesis: LITE owns the bottleneck in EML and pump lasers: 70-80% share, three-year take-or-pay LTAs, 30%+ supply-demand gap unchanged, and repricing backlog still flowing through gross margin. The near term is contractually locked and beat-and-raise is a structural result, not a one-quarter fluke. The asymmetry sits with the bulls for the next two prints because the street is still running an OFC model while management is already at 40% op margin on half the revenue that target assumed.
Verdict: LONG — Conviction: MEDIUM
Catalyst: Q1 print at the $1.25B midpoint with the first triple-digit OCS quarter, plus new Greensboro LTAs over the next two quarters that convert loose capacity into contracted backlog.
Key Risk: The lead CPO customer's scale-up ramp (high-volume shipping H2 CY2027 for 2028 deployments) slips, or lead Tier 1 hyperscaler capex guides down. Management admits NPO/CPO requires 'a new processor, new racks' with silicon landing mid-2027 to early 2028, so there is no retrofit path to soften a delay.
The Tell: Asked directly about Chinese indium phosphide fabs, Hurlston's sentence breaks mid-clause: 'as these Chinese if these Chinese guys come online.' He then volunteers that Chinese suppliers are 'not delivering in the market today' with 'no recourse when they throw out these big numbers.' The stutter on his own words shows the competitive threat is live in his head, not hypothetical.
Friction Level: MODERATE_FRICTION — Both sides accept the print is clean. Disagreement is whether a 2028 CPO/NPO architectural ramp plus a possible Chinese InP entrant justifies the current multiple on 2026 unit economics.
Report not found
The report data is no longer available. Please return to the archive.